National

India khan Oxford coronavirus vaccine olabole ase

July 23, 2020:  Adar Poonawalla, CEO, Serum Institute of India, Pune based manufacturing partner  AstraZeneca para koishe   Oxford coronavirus vaccine, kun laga  Phase I, II trials laga results  toh safe thaka toh  India te ‘Covishield’ matibo. Aro tai khan para   Oxford’s coronavirus vaccine laga  one billion doses khan nishena  olabole ase.

Judi results khan toh positive olaishe  koile toh Poonawala koish”November tak ami khan   bhabona kuri ase etu   vaccine olabole nimete judi trials toh positive thakishe koile toh aro judi DGCI para etu safe ase koile toh.”

Serum Institute of India para Tuesday din  koishe tia khan  COVID-19 vaccine candidate Oxford University and AstraZeneca para trials toh   august moina para shuru kuribo 5,000 Indian volunteers  khan uporte lagi thaka nods khan paikena.

Etu nimete aro bi tin haafta nishena  lobole ase  hospital te  patients khan ke inject kuribole  nimete.Tai kuwa te koikena janaishe.

Serum Institute of India (SII),  duniya laga  the largest vaccine manufacturer  ke chunishe  Oxford aro tai khan laga  partner  AstraZeneca  para  etu vaccine  olabole nimete ekbar tayar hoishe  koile toh.

Serum Institute of India CEO Adar Poonawalla koishe tai khan etu laga daam toh  Rs 1000 nichete rakhibole mun ase.

Etu  vaccine toh bonai ase aro etu toh  Pune aro Mumbai laga  4-5,000 volunteers uporte inject kuribo kun khan  coronavirus infection laga high risk ase  crucial phase 3 trial te   kuntu para dikabo judi etu antidote  toh market te olabole paribo na naparibo.

Poonawalla  koishe etu nimete volunteers khan bishi ase koishe  etu te  bura manu khan   intial  stage te trials laga oxford te nathakibo parhe   Indian  trials te  bura manu aro   health workers khan  thakibo kile koile toh   initial  trial toh    vaccine  safety  nimete ase.

Poonawala koishe etu  hoishe hobole nishena ase ki COVID-19 vaccine nimete duita  nohoile bishi  wala doses laga toh    antidotes laga cases te measles aro dusra beemar khan nishena.

Special  permission luwa laga part te etu company para   komti hoilebi  ek moina te  vaccine laga  70 million doses olabo October tak aro bhabona kuri ase   December tak  100 million ek moina  bithor te olabole  nimete etu  nimete  market toh  olabole ase final approval huwa pichede.